IndraLab

Statements


TNFSF10 inhibits USP5. 1 / 1
| 1

reach
"TRAIL treatment in cancer cells reduced the activity and cleavage of USP5, a deubiquitinase (DUB) previously shown to target unanchored Ub polymers and regulate p53 mediated transcription."